The presence of the 21-hydroxylase deficiency carrier status in hirsute women: Phenotype-genotype correlations

Fertility and Sterility

Volumn 72, Issue 4, 1999, Pages 629-638

  Escobar Morreale, Héctor F ^a   San Millán, José L ^a   Smith, Rhonda R ^b   Sancho, José ^a   Witchel, Selma F ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

21 hydroxylase deficiency; CYP21; Hirsutism; Hyperandrogenism; Molecular genetic analysis

Indexed keywords

CELL DNA; CORTICOTROPIN; HYDROXYPROGESTERONE; TESTOSTERONE; TRIPTORELIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CORTICOTROPIN TEST; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE DETECTION; HIRSUTISM; HUMAN; HYPERANDROGENISM; INTRAMUSCULAR DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; STEROID 21 MONOOXYGENASE DEFICIENCY; TESTOSTERONE BLOOD LEVEL;

17-ALPHA-HYDROXYPROGESTERONE; ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADRENOCORTICOTROPIC HORMONE; ADULT; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GENOTYPE; HETEROZYGOTE; HIRSUTISM; HUMANS; HYPERANDROGENISM; MUTATION; PHENOTYPE; REFERENCE VALUES; SEX HORMONE-BINDING GLOBULIN; STEROID 21-HYDROXYLASE; TESTOSTERONE; TRIPTORELIN;

EID: 0033214141     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00317-9     Document Type: Article

References (32)

1. Miller W.L. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 78:1994;241-246.
2. Azziz R., Dewailly D., Owerbach D. Nonclassic adrenal hyperplasia current concepts. J Clin Endocrinol Metab. 78:1994;810-815.
3. Witchel S.F., Lee P.A. Identification of heterozygotic carriers of 21-hydroxylase deficiency sensitivity of ACTH stimulation tests. Am J Med Genet. 76:1998;337-342.
4. Siegel S.F., Finegold D.N., Lanes R., Lee P.A. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. N Engl J Med. 323:1990;849-854.
5. Eldar Geva T., Hurwitz A., Vecsei P., Palti Z., Milwidsky A., Rosler A. Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia. N Engl J Med. 323:1990;855-863.
6. Escobar-Morreale H., Pazos F., Potau N., Garcia-Robles R., Sancho J.M., Varela C. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperandrogenism role of adrenal and ovarian cytochrome P450c17 alpha. Fertil Steril. 62:1994;521-530.
7. Escobar-Morreale H.F., Serrano-Gotarredona J., García-Robles R., Sancho J., Varela C. Lack of an ovarian function influence on the increased adrenal androgen secretion present in women with functional ovarian hyperandrogenism. Fertil Steril. 67:1997;654-662.
8. Knochenhauer E.S., Cortet-Rudelli C., Cunningham R.D., Conway-Myers B.A., Dewailly D., Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab. 82:1997;479-485.
9. Azziz R., Owerbach D. Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation. Am J Obstet Gynecol. 172:1995;914-918.
10. Blanche H., Vexiau P., Clauin S., Le Gall I., Fiet J., Mornet E., et al. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Hum Genet. 101:1997;56-60.
11. Ostlere L.S., Rumsby G., Holownia P., Jacobs H.S., Rustin M.H., Honour J.W. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol (Oxf). 48:1998;209-215.
12. Witchel S.F., Lee P.A., Suda-Hartman M., Hoffman E.P. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochem Mol Med. 62:1997;151-158.
13. Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 21:1961;1440-1447.
14. Escobar-Morreale H.F., Serrano Gotarredona J., García Robles R., Sancho J., Varela C. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia does idiopathic hirsutism exist? Metabolism. 46:1997;902-907.
15. Escobar-Morreale H.F., Serrano-Gotarredona J., Varela C., García-Robles R., Sancho J.M. Circulating leptin concentrations in women with hirsutism. Fertil Steril. 68:1997;898-906.
16. Escobar-Morreale H.F., Serrano-Gotarredona J., Avila S., Villar-Palasí J., Varela C., Sancho J. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J Clin Endocrinol Metab. 83:1998;2580-2584.
17. Escobar-Morreale H.F., Serrano-Gotarredona J., García-Robles R., Varela C., Sancho J.M. Abnormalities in the serum insulin-like growth factor-I axis in women with hyperandrogenism. Fertil Steril. 70:1998;1090-1100.
18. Ezquieta B., Oliver A., Gracia R., Gancedo P.G. Analysis of steroid 21-hydroxylase gene mutations in the Spanish population. Hum Genet. 96:1995;198-204.
19. Siegel S.F., Lee P.A., Rudert W.A., Swinyard M., Trucco M. Phenotype/genotype correlations in 21-hydroxylase deficiency. Adolesc Pediatr Gynecol. 8:1995;9-16.
20. Siegel S.F., Hoffman E.P., Trucco M. Molecular diagnosis of 21-hydroxylase deficiency detection of four mutations on a single gel. Biochem Med Metab Biol. 51:1994;66-73.
21. Witchel S.F., Nayak S., Suda-Hartman M., Lee P.A. Newborn screening for 21-hydroxylase deficiency results of CYP21 molecular genetic analysis. J Pediatr. 131:1997;328-331.
22. Dawson-Saunders B., Trapp R.G. Basic and clinical biostatistics. 1990;Appleton & Lange, East Norwalk (CT).
23. Azziz R., Wells G., Zacur H.A., Acton R.T. Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation. J Clin Endocrinol Metab. 73:1991;1327-1331.
24. Rumsby G., Avey C.J., Conway G.S., Honour J.W. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms. Clin Endocrinol (Oxf). 48:1998;707-711.
25. Wu D.A., Chung B.C. Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively. J Clin Invest. 88:1991;519-523.
26. Wilkie A.O.M. The molecular basis of genetic dominance. J Med Genet. 31:1994;89-98.
27. Nishi H., Kimura A., Harada H., Koga Y., Adachi K., Matsuyama K., et al. A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. Circulation. 91:1995;2911-2915.
28. Gotoda Y., Wakamatsu N., Kawai H., Nishida Y., Matsumoto T. Missense and nonsense mutations in the lysosomal alpha-mannosidase gene (MANB) in severe and mild forms of alpha-mannosidosis. Am J Hum Genet. 63:1998;1015-1024.
29. Couch R.M., Muller J., Winter J.S. Regulation of the activities of 17-hydroxylase and 17,20-lyase in the human adrenal cortex kinetic analysis and inhibition by endogenous steroids. J Clin Endocrinol Metab. 63:1986;613-618.
30. Dickerman Z., Grant D.R., Faiman C., Winter J.S. Intraadrenal steroid concentrations in man zonal differences and developmental changes. J Clin Endocrinol Metab. 59:1984;1031-1036.
31. Belanger A., Tremblay Y., Vallee M., Provencher P.H., Perron S. Regulation of 21-hydroxylase activity by steroids. Endocr Res. 21:1995;329-341.
32. Speiser P.W., Dupont B., Rubinstein P., Piazza A., Kastelan A., New M.I. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet. 37:1985;650-667.